Long-term survival and post-hoc analysis of toripalimab plus definitive chemoradiotherapy for oesophageal squamous cell carcinoma: insights from the EC-CRT-001 phase II trial
Autor: | Wang, Ruixi, Ling, Yihong, Chen, Baoqing, Zhu, Yujia, Hu, Yonghong, Liu, Mengzhong, Yang, Yadi, Zhang, Li, Lv, Yingxin, Liu, Shiliang, Li, Qiaoqiao, Xi, Mian |
---|---|
Zdroj: | In eClinicalMedicine September 2024 75 |
Databáze: | ScienceDirect |
Externí odkaz: |